ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.1089
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 1089-1089
Author(s):
Angelos Koutras
◽
Flora Zagouri
◽
Georgia-Angeliki Koliou
◽
Georgios Lazaridis
◽
Dimitrios Tryfonopoulos
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
Second Line
◽
Previously Treated
◽
Her 2
Download Full-text
Related Documents
Cited By
References
Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First‐Line Treatment for HER‐2‐positive Locally Recurrent or Metastatic Breast Cancer
The Oncologist
◽
10.1634/theoncologist.2011-0344
◽
2012
◽
Vol 17
(4)
◽
pp. 469-475
◽
Cited By ~ 34
Author(s):
Miguel Martín
◽
Anatoly Makhson
◽
Joseph Gligorov
◽
Mikhail Lichinitser
◽
Ana Lluch
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
Her 2
◽
Locally Recurrent
◽
First Line Treatment
Download Full-text
194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)
European Journal of Cancer
◽
10.1016/s0959-8049(12)70262-9
◽
2012
◽
Vol 48
◽
pp. S97
◽
Cited By ~ 1
Author(s):
A. Urruticoechea
◽
P. Canney
◽
R. Separovic
◽
T. Bachelot
◽
J. Efran
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
Second Line
◽
Her2 Positive
Download Full-text
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-003-0632-x
◽
2003
◽
Vol 52
(2)
◽
pp. 147-152
◽
Cited By ~ 30
Author(s):
Michela Donadio
◽
Mara Ardine
◽
Alfredo Berruti
◽
Giuliana Ritorto
◽
Elena Fea
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
Second Line
Download Full-text
A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
Journal of Cancer Research and Clinical Oncology
◽
10.1007/s00432-009-0642-0
◽
2009
◽
Vol 136
(1)
◽
pp. 115-121
◽
Cited By ~ 4
Author(s):
George Orphanos
◽
Athanasios Alexopoulos
◽
Savvoula Malliou
◽
George Ioannidis
◽
Alexandros Ardavanis
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Breast
◽
Line Treatment
◽
Second Line
◽
Previously Treated
Download Full-text
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: Results of a phase II study
Annals of Oncology
◽
10.1023/a:1008292332166
◽
1998
◽
Vol 9
(1)
◽
pp. 45-50
◽
Cited By ~ 10
Author(s):
U. Klaassen
◽
H. Wilke
◽
A. Harstrick
◽
C. Philippou Pari
◽
D. Strumberg
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
Second Line
Download Full-text
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
Annals of Oncology
◽
10.1023/a:1008361711049
◽
2000
◽
Vol 11
(7)
◽
pp. 873-875
◽
Cited By ~ 41
Author(s):
C. Nicolaides
◽
M.A. Dimopoulos
◽
E. Samantas
◽
D. Bafaloukos
◽
C. Kalofonos
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
Second Line
◽
Oncology Group
◽
First Line
Download Full-text
Phase II study of second-line treatment with high-dose cyclophosphamide in recurrent metastatic breast cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s002800050400
◽
1996
◽
Vol 37
(4)
◽
pp. 377-381
Author(s):
Flemming Hansen
◽
Peter Møller
◽
Torben Skovsgaard
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
High Dose
◽
Line Treatment
◽
Second Line
Download Full-text
Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study
Clinical Breast Cancer
◽
10.3816/cbc.2010.n.041
◽
2010
◽
Vol 10
(4)
◽
pp. 313-317
◽
Cited By ~ 3
Author(s):
Juan de la Haba-Rodriguez
◽
Rosario González Mancha
◽
Gumersindo Pérez Manga
◽
Enrique Aranda Aguilar
◽
José Manuel Baena Cañada
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
406 POSTER Safety and efficacy of sunitinib malate (SU11248) as second-line therapy in metastatic breast cancer (MBC) patients: preliminary results from a phase II study
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(05)80704-9
◽
2005
◽
Vol 3
(2)
◽
pp. 113-114
◽
Cited By ~ 3
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Second Line
◽
Second Line Therapy
◽
Sunitinib Malate
◽
Safety And Efficacy
◽
Line Therapy
Download Full-text
A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer
Clinical & Translational Oncology
◽
10.1007/s12094-008-0295-5
◽
2008
◽
Vol 10
(12)
◽
pp. 817-825
◽
Cited By ~ 2
Author(s):
Juan Bayo
◽
María Lomas
◽
Javier Salvador
◽
Alberto Moreno
◽
Manuel Ruiz
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Multicentre Phase
◽
Her 2
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close